ProMIS Neurosciences, Inc.
PMN
$9.75
$0.040.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.62M | -39.72M | -29.28M | -8.43M | -934.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 796.10K | 852.00K | -4.26M | -17.81M | -18.06M |
| Change in Net Operating Assets | 4.24M | 10.75M | 5.99M | 2.07M | -2.82M |
| Cash from Operations | -35.58M | -28.12M | -27.55M | -24.17M | -21.82M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00 | -700.00 | -700.00 | -700.00 | -700.00 |
| Cash from Investing | -700.00 | -700.00 | -700.00 | -700.00 | -700.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.33M | 20.25M | 20.72M | 27.69M | 27.69M |
| Repurchase of Common Stock | -10.17M | -10.17M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.87M | 10.87M | 697.70K | -- | -- |
| Cash from Financing | 91.03M | 20.94M | 21.41M | 27.69M | 27.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.45M | -7.17M | -6.14M | 3.52M | 5.87M |